Dutch researchers uncover distinct chemical markers in babies’ stool that may predict allergy development years before symptoms arise, highlighting a critical window for early intervention.
Dutch researchers have found that the chemistry of an infant’s stool may offer an early clue to later allergy risk, with measurable differences appearing well before symptoms develop.
The study, published in Metabolomics, followed 72 babies considered to be at higher hereditary risk of allergic disease through their first year. All were exclusively breastfed for at least 16 weeks, allowing the team to examine how later feeding changes affected gut chemistry without the confounding effects of early formula use. Parents recorded allergy symptoms, birth details and the timing of complementary foods, while researchers collected stool samples at three points during infancy.
Rather than focusing only on which microbes were present, the team measured what those microbes were producing. Using chemical profiling and cell-count techniques, they tracked hundreds of metabolites, including bile acids, fatty acids, B vitamins and amino-acid by-products, alongside absolute counts of key bacterial groups. That approach matters because microbiome studies based only on relative abundance can obscure whether a species truly falls or merely appears to do so as other microbes expand.
The clearest pattern was that time itself reshaped the infant gut. From three months to 12 months, the metabolome changed markedly, especially in pathways linked to aromatic amino acids, bile acids, vitamins and fatty acids. The shift tracked the normal ecological progression of infancy, as the breastfed gut gives way to a more diverse, adult-like microbial community. Feeding changes also had a strong effect: the start of solid foods and the end of breastfeeding both altered stool chemistry in ways the researchers said were statistically significant.
Birth mode left its own imprint. Infants delivered by caesarean section showed a different metabolomic profile from those born vaginally, and the gap lasted until six months of age. That finding fits earlier research linking caesarean delivery with early microbiome disruption and a higher risk of some immune-related conditions. In practical terms, the study suggests the effects of birth mode extend beyond which bacteria colonise the gut and into the molecules those microbes generate.
The most striking result came from the children who later developed allergies. Before 16 weeks of age, they had fewer Bifidobacterium species and higher levels of polyunsaturated fatty acids in their stool than infants who did not go on to become allergic. Bifidobacteria are widely seen as important in early immune development because they help process human milk sugars into compounds that support immune tolerance. The fatty-acid signal may point to altered lipid handling in the pre-allergy gut, although the researchers said the exact cause remains unclear.
The findings add to growing evidence that the first months of life may be a critical window for allergy prevention. Similar work has suggested that early metabolite patterns can help predict later atopic disease, including food allergy. For parents and clinicians, the message is cautious but important: the gut’s chemical environment changes rapidly in infancy, and those changes may help shape whether a child moves towards or away from allergy risk.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.
